cagrisema cagrilintide semaglutide phase 3 obesity Efficacy and safety of co-administered once-weekly 2·4 mg with once-weekly 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, 2 trial Novo Nordisk Submits CagriSema for
Description
so I recommend having a nurse train you once
Everything Ive gotten from Vitastir has been top notch

Combining compounds multiplies the number of potential side effects at play, and stacking unapproved research chemicals without medical supervision carries meaningfully more risk than using a single compound on its own

F., Lamberth, K., Vilhelmsen, T